About the Cohort
Demographics
37% percent of the cohort lives in rural areas, and patients travel an average of 56 miles one-way to clinic. Over a quarter of patients have not finished high school, and over one-half live under the federal poverty line. The cohort is distinctive among large clinical cohorts in the US as its demographic profile represents the growing HIV epidemic in the southeastern US.
Patients are presented with a tiered consent that allows them to participate in one or more levels, starting with contribution of their data, storage of existing and / or excess samples, collection of Patient Reported Outcomes and/or willingness to be contacted for study participation. Greater than 95% of patients provide full consent.


HIV and Clinical Characteristics
HIV Outcomes
Upon entry into care, 36% of UCHCC participants had CD4 counts less than 200, 16% between 200-350, and nearly half greater than 350 cells/mL. The median nadir CD4 count is 193 with an IQR of 43-396. Currently, over three-quarters of participants have CD4 cell counts greater than 350, 13% between 200-350, and 10% less 200. Over 90% of participants have undetectable HIV RNA.

Comorbidities
Assessing clinical comorbidities is becoming increasingly important in HIV research, especially among aging people living with HIV. Among UCHCC participants, 40% have had a prior AIDS-defining condition, 40% have hypertension, one-third have liver disease, 31% have cardiovascular disease, over one-quarter have renal disease, and 12% have diabetes.

Patient-Reported Outcomes
Substance Use and Mental Health
Notably, over half of UCHCC participants report depressive symptoms, and over a quarter report anxiety symptoms.

Other Outcomes
